Patents by Inventor Jidong Liu

Jidong Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250127760
    Abstract: A composition and a use of the composition in the preparation of a medicament for treating eye diseases. The composition includes 0.5-1.5% by weight of a muscarinic acetylcholine receptor M3 agonist; 0.005-0.5% by weight of naphazoline, a pharmaceutically acceptable salt thereof or a combination thereof; and 0.1-1% by weight of ketorolac tromethamine. While enhancing the effect of a muscarinic acetylcholine receptor M3 agonist such as a pilocarpine active ingredient in treating presbyopia, the composition effectively significantly reduces or even eliminates side effects caused by the pilocarpine active ingredient.
    Type: Application
    Filed: December 27, 2022
    Publication date: April 24, 2025
    Inventors: Jidong LIU, Qiang YANG, Dan LI, Yang JIN, Lili ZHAO
  • Publication number: 20250051255
    Abstract: The present invention provides a method for synthesizing tyloxapol of formula (I), including the following steps: first reacting p-tert-octylphenol of formula (III) with formaldehyde under alkaline conditions to obtain 2,5-dimethylol p-tert-octylphenol of formula (IV); then reacting 2,5-dimethylol p-tert-octylphenol with p-tert-octylphenol of formula (III) under acidic conditions to obtain the phenolic resin of formula (II); and finally, reacting the phenolic resin of formula (II) with ethylene oxide to obtain tyloxapol of formula (I).
    Type: Application
    Filed: December 20, 2022
    Publication date: February 13, 2025
    Inventors: Jidong LIU, Qiang YANG, Yu LEI, Bo WEN
  • Publication number: 20250042939
    Abstract: Provided is a method for preparing oxidized glutathione and a new crystal form and impurity thereof, including the following steps: using dimethyl sulfoxide (DMSO) as an oxidizing agent to oxidize reduced glutathione to crude oxidized glutathione; and recrystallizing and refining in purified water to obtain high-purity heptahydrate crystals of oxidized glutathione.
    Type: Application
    Filed: December 20, 2022
    Publication date: February 6, 2025
    Inventors: Jidong LIU, Qiang YANG, Yu LEI, Jinsong SHEN
  • Publication number: 20250032513
    Abstract: The invention belongs to the field of drug preparations and discloses an ophthalmic sustained-release drug delivery system. The ophthalmic sustained-release drug delivery system consists of biocompatible solid and liquid substances, as well as substances with pharmacological activity and pharmacologically acceptable salt of the substances, and can be mixed with a matrix which is liquid at room temperature, has the density larger than that of water and almost incompatible with water, so that the drug release rate and the degradation time of the delivery system are changed. According to the sustained-release drug delivery system, a drug is solidified into a ball at an eye, so that the drug liquidity is reduced, drug release is sustained, the administration times is reduced, and the compliance of patients is improved.
    Type: Application
    Filed: October 17, 2024
    Publication date: January 30, 2025
    Inventors: Qiang Yang, Jidong Liu
  • Patent number: 12150946
    Abstract: The invention belongs to the field of drug preparations and discloses an ophthalmic sustained-release drug delivery system. The ophthalmic sustained-release drug delivery system consists of biocompatible solid and liquid substances, as well as substances with pharmacological activity and pharmacologically acceptable salt of the substances, and can be mixed with a matrix which is liquid at room temperature, has the density larger than that of water and almost incompatible with water, so that the drug release rate and the degradation time of the delivery system are changed. According to the sustained-release drug delivery system, a drug is solidified into a ball at an eye, so that the drug liquidity is reduced, drug release is sustained, the administration times is reduced, and the compliance of patients is improved.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: November 26, 2024
    Assignee: Shenyang Xingqi Pharmaceutical Co., Ltd.
    Inventors: Qiang Yang, Jidong Liu
  • Publication number: 20240343738
    Abstract: The present invention belongs to the field of medicine and relates to a method for preparing pranoprofen. The present invention also relates to a composition containing pranoprofen and impurities, a quality control method, an intermediate compound for synthesizing pranoprofen and a preparation method thereof. The method of the present invention overcomes the deficiencies of the prior art, shortens the synthetic route, lowers the requirements of process conditions, simplifies the process operation, improves labor safety, is more suitable for industrial production, is more environmentally friendly and has higher yield.
    Type: Application
    Filed: June 15, 2022
    Publication date: October 17, 2024
    Inventors: Jidong LIU, Qiang YANG, Wenzhao LI, Yang SUN, Xueyu JI
  • Publication number: 20240329431
    Abstract: In general, one aspect disclosed features a spectacle lens, comprising: a central zone having an optical center corresponding to the visual axis of an eye of a patient; and a peripheral zone peripheral to the central zone and comprising: a first zone having a first thickness, and a second zone having a second thickness, wherein: the second thickness varies from the first thickness, and a distance from the second zone to the optical center of the central zone is selected to generate pincushion distortion or barrel distortion in the eye of the patient.
    Type: Application
    Filed: May 7, 2024
    Publication date: October 3, 2024
    Inventors: Jerome A. LEGERTON, Jidong LIU, Gaozhi LIU
  • Patent number: 12050369
    Abstract: In general, one aspect disclosed features a flexible lens element for application to a spectacle lens, the flexible lens element comprising: a central zone having an optical center corresponding to the visual axis of an eye of a patient; and a peripheral zone peripheral to the central zone and comprising: a first zone having a first thickness, and a second zone having a second thickness, wherein: the second thickness varies from the first thickness, and a distance from the second zone to the optical center of the central zone is selected to generate pincushion distortion or barrel distortion in the eye of the patient.
    Type: Grant
    Filed: July 3, 2023
    Date of Patent: July 30, 2024
    Assignee: Shenyang Kangende Medical Science and Technology Co., Ltd.
    Inventors: Jerome A. Legerton, Jidong Liu, Gaozhi Liu
  • Publication number: 20240210733
    Abstract: A contact lens for treating myopia of an eye of a patient comprises an anterior surface; and a posterior surface having a semi-meridian defining: a central compression zone to contact the pretreatment cornea, a volume control zone peripheral to the central compression zone, a secondary compression zone to contact the pretreatment cornea, wherein the secondary compression zone is peripheral to the volume control zone, a peripheral relief zone peripheral to the secondary compression zone, a landing zone to contact the pretreatment cornea, wherein the landing zone is peripheral to the peripheral relief zone, and an edge terminus peripheral to the landing zone.
    Type: Application
    Filed: March 8, 2024
    Publication date: June 27, 2024
    Applicant: SHENYANG KANGNEDE MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Jerome A. LEGERTON, Jidong LIU, Gaozhi LIU
  • Publication number: 20240210732
    Abstract: A contact lens for treating myopia of an eye of a patient comprises an anterior surface; and a posterior surface having a semi-meridian defining: a central compression zone to contact the pretreatment cornea, a volume control zone peripheral to the central compression zone, a secondary compression zone to contact the pretreatment cornea, wherein the secondary compression zone is peripheral to the volume control zone, a peripheral relief zone peripheral to the secondary compression zone, a landing zone to contact the pretreatment cornea, wherein the landing zone is peripheral to the peripheral relief zone, and an edge terminus peripheral to the landing zone.
    Type: Application
    Filed: March 8, 2024
    Publication date: June 27, 2024
    Applicant: SHENYANG KANGENDE MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Jerome A. LEGERTON, Jidong Liu, Gaozhi Liu
  • Patent number: 11977278
    Abstract: In general, one aspect disclosed features a scleral contact lens for an eye of a patient, the scleral contact lens comprising: an anterior surface; and a posterior surface, the posterior surface comprising: a central optic zone defined by a base curve according to an apical radius of the cornea of the eye; a peripheral corneal zone peripheral to the central optic zone, a clearance control zone peripheral to the optic zone, and a scleral landing zone peripheral to the clearance control zone, the scleral landing zone having a single surface shape.
    Type: Grant
    Filed: July 21, 2021
    Date of Patent: May 7, 2024
    Assignee: Shenyang Kangende Medical Science and Technology Co., Ltd.
    Inventors: Jerome A. Legerton, Jidong Liu, Gaozhi Liu
  • Publication number: 20240118561
    Abstract: In general, one aspect disclosed features a scleral contact lens for an eye of a patient, the scleral contact lens comprising: an anterior surface; and a posterior surface, the posterior surface comprising: a central optic zone defined by a base curve according to an apical radius of the cornea of the eye; a peripheral corneal zone peripheral to the central optic zone, a clearance control zone peripheral to the optic zone, and a scleral landing zone peripheral to the clearance control zone, the scleral landing zone having a single surface shape.
    Type: Application
    Filed: December 5, 2023
    Publication date: April 11, 2024
    Inventors: Jerome A. Legerton, Jidong Liu, Gaozhi Liu
  • Patent number: 11953761
    Abstract: A contact lens for treating myopia of an eye of a patient comprises an anterior surface; and a posterior surface having a semi-meridian defining: a central compression zone to contact the pretreatment cornea, a volume control zone peripheral to the central compression zone, a secondary compression zone to contact the pretreatment cornea, wherein the secondary compression zone is peripheral to the volume control zone, a peripheral relief zone peripheral to the secondary compression zone, a landing zone to contact the pretreatment cornea, wherein the landing zone is peripheral to the peripheral relief zone, and an edge terminus peripheral to the landing zone.
    Type: Grant
    Filed: February 15, 2023
    Date of Patent: April 9, 2024
    Assignee: Shenyang Kangende Medical Science and Technology Co., Ltd.
    Inventors: Jerome A. Legerton, Jidong Liu, Gaozhi Liu
  • Publication number: 20240085725
    Abstract: In general, one aspect disclosed features a lens comprising: a central zone having an optical center corresponding to the visual axis of an eye of a patient; and a peripheral zone peripheral to the central zone and comprising: a first zone having a first thickness, and a second zone having a second thickness, wherein: the second thickness varies from the first thickness, and a distance from the second zone to the optical center of the central zone is selected to generate pincushion distortion or barrel distortion in the eye of the patient.
    Type: Application
    Filed: July 7, 2021
    Publication date: March 14, 2024
    Inventors: Jerome A. LEGERTON, Jidong LIU, Gaozhi LIU
  • Publication number: 20230350233
    Abstract: In general, one aspect disclosed features a flexible lens element for application to a spectacle lens, the flexible lens element comprising: a central zone having an optical center corresponding to the visual axis of an eye of a patient; and a peripheral zone peripheral to the central zone and comprising: a first zone having a first thickness, and a second zone having a second thickness, wherein: the second thickness varies from the first thickness, and a distance from the second zone to the optical center of the central zone is selected to generate pincushion distortion or barrel distortion in the eye of the patient.
    Type: Application
    Filed: July 3, 2023
    Publication date: November 2, 2023
    Inventors: Jerome A. LEGERTON, Jidong LIU, Gaozhi LIU
  • Patent number: 11774779
    Abstract: A contact lens for treating myopia of an eye of a patient comprises an anterior surface; and a posterior surface having a semi-meridian defining: a central compression zone to contact the pretreatment cornea, a volume control zone peripheral to the central compression zone, a secondary compression zone to contact the pretreatment cornea, wherein the secondary compression zone is peripheral to the volume control zone, a peripheral relief zone peripheral to the secondary compression zone, a landing zone to contact the pretreatment cornea, wherein the landing zone is peripheral to the peripheral relief zone, and an edge terminus peripheral to the landing zone.
    Type: Grant
    Filed: March 3, 2021
    Date of Patent: October 3, 2023
    Assignee: SHENYANG KANGENDE MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Jerome A. Legerton, Jidong Liu
  • Patent number: 11768388
    Abstract: In general, one aspect disclosed features a flexible lens element for application to a spectacle lens, the flexible lens element comprising: a central zone having an optical center corresponding to the visual axis of an eye of a patient; and a peripheral zone peripheral to the central zone and comprising: a first zone having a first thickness, and a second zone having a second thickness, wherein: the second thickness varies from the first thickness, and a distance from the second zone to the optical center of the central zone is selected to generate pincushion distortion or barrel distortion in the eye of the patient.
    Type: Grant
    Filed: July 7, 2021
    Date of Patent: September 26, 2023
    Assignee: Shenyang Kangende Medical Science and Technology Co., Ltd.
    Inventors: Jerome A. Legerton, Jidong Liu, Gaozhi Liu
  • Publication number: 20230244092
    Abstract: In general, one aspect disclosed features a flexible lens element for application to a spectacle lens, the flexible lens element comprising: a central zone having an optical center corresponding to the visual axis of an eye of a patient; and a peripheral zone peripheral to the central zone and comprising: a first zone having a first thickness, and a second zone having a second thickness, wherein: the second thickness varies from the first thickness, and a distance from the second zone to the optical center of the central zone is selected to generate pincushion distortion or barrel distortion in the eye of the patient.
    Type: Application
    Filed: July 7, 2021
    Publication date: August 3, 2023
    Inventors: Jerome A. Legerton, Jidong Liu
  • Publication number: 20230221581
    Abstract: A contact lens for treating myopia of an eye of a patient comprises an anterior surface; and a posterior surface having a semi-meridian defining: a central compression zone to contact the pretreatment cornea, a volume control zone peripheral to the central compression zone, a secondary compression zone to contact the pretreatment cornea, wherein the secondary compression zone is peripheral to the volume control zone, a peripheral relief zone peripheral to the secondary compression zone, a landing zone to contact the pretreatment cornea, wherein the landing zone is peripheral to the peripheral relief zone, and an edge terminus peripheral to the landing zone.
    Type: Application
    Filed: February 15, 2023
    Publication date: July 13, 2023
    Applicant: SHENYANG KANGENDE MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Jerome A. Legerton, Jidong Liu
  • Publication number: 20230204976
    Abstract: In general, one aspect disclosed features a scleral contact lens for an eye of a patient, the scleral contact lens comprising: an anterior surface; and a posterior surface, the posterior surface comprising: a central optic zone defined by a base curve according to an apical radius of the cornea of the eye; a peripheral corneal zone peripheral to the central optic zone, a clearance control zone peripheral to the optic zone, and a scleral landing zone peripheral to the clearance control zone, the scleral landing zone having a single surface shape.
    Type: Application
    Filed: July 21, 2021
    Publication date: June 29, 2023
    Inventors: Jerome A. Legerton, Jidong Liu